TRUMP’S SHOCK ULTIMATUM

President Donald Trump has issued a bold ultimatum to the pharmaceutical industry, giving major drug companies 60 days to significantly lower prescription prices or face strict federal intervention.

The White House reportedly sent letters to leading pharmaceutical CEOs outlining the demand for “Most-Favored-Nation” pricing — ensuring that Americans pay no more for medications than citizens in other wealthy nations.

This marks one of Trump’s most aggressive actions to address the high cost of prescription drugs, a problem that has forced millions of Americans to ration or skip vital medications.

Pharmaceutical companies responded with concern, warning that drastic price cuts could hinder medical innovation and slow the development of new treatments.

However, critics argue that this defense has long been used by Big Pharma to protect enormous profit margins while leaving patients struggling to afford care.

Trump has portrayed the move as a battle for fairness, accusing foreign governments of “global freeloading” by benefiting from lower prices while Americans pay more for the same drugs.

The standoff sets the stage for a major political and economic confrontation that could reshape drug pricing policies and alter the future of U.S. healthcare.